Cancer rates did not increase among metal-on-metal hip implant patients in the first seven years after surgery, according to an analysis of the U.K.'s National Joint Registry. For the study, researchers compared the incidence of new cancer diagnoses for more than 40,000 patients with metal-on-metal hip implants to patients with different bearing surfaces and the general population.
The analysis showed that cancer diagnoses were lower for patients with metal-on-metal hip replacements five years after surgery than patients with hip replacements using other bearing surfaces.
The research is telling in light of ongoing litigation regarding DePuy's recalled hip implants. The device, which was made from a cobalt and chromium alloy, released metal debris into patients' bodies and caused adverse outcomes such as tissue death and increased metal ions in the bloodstream.
The analysis showed that cancer diagnoses were lower for patients with metal-on-metal hip replacements five years after surgery than patients with hip replacements using other bearing surfaces.
The research is telling in light of ongoing litigation regarding DePuy's recalled hip implants. The device, which was made from a cobalt and chromium alloy, released metal debris into patients' bodies and caused adverse outcomes such as tissue death and increased metal ions in the bloodstream.
More Articles on Orthopedic Devices:
American Joint Replacement Registry Today & Tomorrow: Q&A With Director of Research Dr. Caryn Etkin
DiFusion CleanFUZE Clinical Trials Demonstrate Positive Outcomes
23 Spine Devices Receive FDA 510(k) Clearance in August